(Total Views: 407)
Posted On: 07/23/2021 4:20:21 AM
Post# of 653
$RLFTF $NRXP July 23 - RELIEF REPORTS THAT ITS U.S. COLLABORATION PARTNER HAS ANNOUNCED SUCCESSFUL COMMERCIAL FORMULATION FOR AVIPTADIL
Ad Hoc Announcement pursuant to Art. 53 LR,
23 July 2021 - https://relieftherapeutics.com/newsblog/relie...-aviptadil
Ad Hoc Announcement pursuant to Art. 53 LR,
23 July 2021 - https://relieftherapeutics.com/newsblog/relie...-aviptadil
(0)
(0)
$MJ
